Real‐World Outcomes After Dupilumab Initiation for Pediatric Chronic Rhinosinusitis with Nasal Polyps

OBJECTIVE: To evaluate whether dupilumab initiation is associated with reduced short-term flare burden, healthcare utilization, and surgical escalation in pediatric patients with chronic rhinosinusitis with nasal polyps (CRSwNP). STUDY DESIGN: Retrospective cohort study. SETTING: TriNetX United States Collaborative Network. METHODS: Patients aged ≤18 years with chronic rhinosinusitis with nasal polyps were identified between January 1, 2015, and December 31, 2024. Dupilumab-treated patients were indexed at treatment initiation and propensity score-matched 1:1 to nondupilumab controls indexed at a systemic corticosteroid burst based on asthma, atopic dermatitis, allergic rhinitis, and prior endoscopic sinus surgery. Outcomes within 12 months were compared using risk ratios. RESULTS: In 442 matched patients (221 per cohort), dupilumab-treated patients had lower rates of acute sinusitis (12/221 [5.4%] vs 31/221 [14.0%]; risk ratio [RR] 0.39; 95% CI: 0.20-0.73; P = .002), systemic corticosteroid bursts (80/221 [36.2%] vs 101/221 [45.7%]; RR 0.79; 95% CI: 0.63-0.99; P = .042), and functional endoscopic sinus surgery (19/221 [8.6%] vs 38/221 [17.2%]; RR 0.50; 95% CI: 0.30-0.84; P = .007). Nasal polyp diagnoses were more frequently documented in the dupilumab-treated cohort (148/221 [67.0%] vs 95/221 [43.0%]; P < .0001), while emergency department visits (16/221 [7.2%] vs 27/221 [12.2%]; P = .078) and inpatient admissions (12/221 [5.4%] vs 16/221 [7.2%]; P = .435) were similar between cohorts. CONCLUSION: These findings suggest that dupilumab may be a steroid-sparing and surgery-sparing option in pediatric CRSwNP.

Authors

Institutions

Publication Details

Journal
Otolaryngology
Published
2026-11-17
DOI
https://doi.org/10.1002/ohn.70523
Primary Topic
Sinusitis and nasal conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Real‐World Outcomes After Dupilumab Initiation for Pediatric Chronic Rhinosinusitis with Nasal Polyps

Michele M. Carr, Deepthi S. Akella, Paula Valeria Guerra-Navarro, Maaz S. Haji et al.
5 links
Otolaryngology
Sinusitis and nasal conditions
article

Real‐World Outcomes After Dupilumab Initiation for Pediatric Chronic Rhinosinusitis with Nasal Polyps

Michele M. Carr, Deepthi S. Akella, Paula Valeria Guerra-Navarro, Maaz S. Haji, Abraham A Kassem, Alexa Ibrahim
article en

Abstract

OBJECTIVE: To evaluate whether dupilumab initiation is associated with reduced short-term flare burden, healthcare utilization, and surgical escalation in pediatric patients with chronic rhinosinusitis with nasal polyps (CRSwNP). STUDY DESIGN: Retrospective cohort study. SETTING: TriNetX United States Collaborative Network. METHODS: Patients aged ≤18 years with chronic rhinosinusitis with nasal polyps were identified between January 1, 2015, and December 31, 2024. Dupilumab-treated patients were indexed at treatment initiation and propensity score-matched 1:1 to nondupilumab controls indexed at a systemic corticosteroid burst based on asthma, atopic dermatitis, allergic rhinitis, and prior endoscopic sinus surgery. Outcomes within 12 months were compared using risk ratios. RESULTS: In 442 matched patients (221 per cohort), dupilumab-treated patients had lower rates of acute sinusitis (12/221 [5.4%] vs 31/221 [14.0%]; risk ratio [RR] 0.39; 95% CI: 0.20-0.73; P = .002), systemic corticosteroid bursts (80/221 [36.2%] vs 101/221 [45.7%]; RR 0.79; 95% CI: 0.63-0.99; P = .042), and functional endoscopic sinus surgery (19/221 [8.6%] vs 38/221 [17.2%]; RR 0.50; 95% CI: 0.30-0.84; P = .007). Nasal polyp diagnoses were more frequently documented in the dupilumab-treated cohort (148/221 [67.0%] vs 95/221 [43.0%]; P < .0001), while emergency department visits (16/221 [7.2%] vs 27/221 [12.2%]; P = .078) and inpatient admissions (12/221 [5.4%] vs 16/221 [7.2%]; P = .435) were similar between cohorts. CONCLUSION: These findings suggest that dupilumab may be a steroid-sparing and surgery-sparing option in pediatric CRSwNP.

Otolaryngology
Rosalind Franklin University of Medicine and Science (US), Jacobs Institute (US), University at Buffalo, State University of New York (US), University of Missouri (US)
Good health and well-being
Sinusitis and nasal conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon